LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
8.69
+0.34 (4.07%)
Apr 28, 2026, 4:00 PM EDT - Market closed
LeonaBio Employees
LeonaBio had 19 employees as of December 31, 2025. The number of employees decreased by 7 or -26.92% compared to the previous year.
Employees
19
Change (1Y)
-7
Growth (1Y)
-26.92%
Revenue / Employee
n/a
Profits / Employee
-$5,558,368
Market Cap
81.63M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Gossamer Bio | 162 |
| Sangamo Therapeutics | 142 |
| Adicet Bio | 102 |
| Pelthos Therapeutics | 92 |
| PolyPid | 75 |
| aTyr Pharma | 60 |
| Q32 Bio | 24 |
LONA News
- 5 days ago - LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer - GlobeNewsWire
- 4 weeks ago - LeonaBio Reports Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - LeonaBio Transcript: EGM 2026 - Transcripts
- 3 months ago - LeonaBio Appoints Industry Veteran Mark F. Kubik as Chief Business Officer - GlobeNewsWire
- 4 months ago - Why Is Athira Pharma Stock Spiking After Breast Cancer Asset Acquisition? - Benzinga
- 4 months ago - Athira Pharma recovers from Alzheimer's failure with breast cancer pivot and $90M investment - GeekWire
- 4 months ago - LeonaBio Transcript: Status Update - Transcripts
- 4 months ago - Athira Pharma Announces Exclusive License to Lasofoxifene Phase 3 Development Program for Metastatic Breast Cancer Candidate and a Financing for up to $236 Million - GlobeNewsWire